BioSpace News Archive

This Women’s Initiative is in conjunction with the Company’s expanded FDA approval for cardiogenic shock associated with cardiomyopathy.

This new product offering from Lonza is a result of a worldwide marketing and distribution agreement with Kirkstall.

The Omni Lite offers many of the same features, benefits and functionality as the popular, award-winning Omni, and was developed specifically for users seeking only basic operation.

This sterile-packed innovative system adds to the original implant design also available, while providing internal fixation via a dual threaded construct which is inserted between the proximal and middle phalanges so that the opposing threads fixate within the phalangeal canals of the toe to compress the proximal interphalangeal (PIP) joint.

The Company expects a six-month review cycle by FDA.

A new study appearing in STEM CELLS Translational Medicine shows how understanding the way a type of molecule called CD133 functions might contribute to an understanding of the mechanisms involved in kidney repair.

The system is currently under review with the Food and Drug Administration.